STOCKHOLM, Sweden, Jan. 27, 2004 (PRIMEZONE) -- As previously announced, on September 22, 2003, the United States Court of Appeals for the Federal Circuit vacated the $24 million September 10, 2002 judgment entered against Elekta after a trial in the United States District Court for the Southern District of California. The appeals court's decision absolved Elekta of all liability.
On October 30, 2003, the appeals court announced its decision to deny a petition from Medical Instrumentation and Diagnostics Corporation (Midco), Elekta's opponent in the patent dispute, to reconsider its ruling issued on September 22, 2003.
On Monday, January 26, 2004, Midco filed a petition for a writ of certiorari with the United States Supreme Court, requesting review of the Federal Circuit's judgment.
A petition for a writ of certiorari is a petition requesting the right to file an appeal. Grant of this remedy is unusual. In the context of patent cases, the Supreme Court typically grants certiorari in only a very few cases a year.
For further information, please contact: International: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ), Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com United States: Lars Jonsteg, VP Investor Relations North America, Elekta, USA Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.com
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
For additional information about Elekta, please visit www.elekta.com
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2004/01/27/20040127BIT00810/wkr0001.doc
http://www.waymaker.net/bitonline/2004/01/27/20040127BIT00810/wkr0002.pdf